1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Precision cancer medicine : Concepts, current practice, and future developments
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors
(
- Contribution to journal › Article
- 2021
-
Mark
NTRK Alterations in pediatric high-risk malignancies identified through European clinical sequencing programs constitute promising drug targets
(
- Contribution to journal › Letter